| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.36B | -25.2% |
| R&D Expense | $381.0M | -12.9% |
| SG&A Expense | $924.0M | -32.6% |
| Pre-tax Income | -$1.03B | +72.1% |
| Income Tax | $1.0M | -50.0% |
| Net Income | -$1.03B | +72.1% |
| EPS (Basic) | -$1.17 | +84.4% |
| EPS (Diluted) | -$1.17 | +84.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.34B | +1.4% |
| Current Assets | $22.92B | +18.8% |
| Total Assets | $23.34B | +18.0% |
| Current Liabilities | $16.25B | +31.6% |
| Total Liabilities | $16.38B | +31.3% |
| Stockholders' Equity | $6.96B | -4.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$852.0M | +3.7% |
| Investing Cash Flow | -$60.0M | +74.8% |
| Financing Cash Flow | $0 | -100.0% |